HK Stock Movement | CHONGQING M&E (02722) Rises Nearly 7%, Surges Over 40% in Past 4 Sessions as Company Expects Strong Annual Growth

Stock News
Nov 11

CHONGQING M&E (02722) gained nearly 7%, extending its rally to over 40% in the past four trading sessions. At press time, the stock rose 6.75% to HK$2.53, with a turnover of HK$69.43 million.

The company recently held a reverse roadshow for investors on November 5-6. According to its announcement, CHONGQING M&E has actively adapted to market changes, optimized internal operations, and enhanced lean management efficiency across all business segments this year.

Based on unaudited financial statements for January-October 2025, the company expects to maintain steady growth through year-end, with both revenue and total profit projected to achieve significant year-on-year growth, essentially meeting annual operational targets.

Regarding CHONGQING CUMMINS' full-year 2025 outlook, the company noted that the unit has performed well in its traditional strong markets, with growth aligning with initial forecasts. Breakthroughs were made in new markets such as data center backup power solutions. CHONGQING CUMMINS' unaudited January-October 2025 financials indicate both revenue and total profit are expected to show strong year-on-year growth, reaching record highs.

Additionally, MSCI recently included CHONGQING M&E in its Global Small Cap Index constituents, effective after market close on November 24, 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10